Glycopeptide resistance in coagulase-negative staphylococci isolated in blood cultures from patients with hematological malignancies during three decades

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 30, Issue 11, 2011, Pages 1349-1354

  Ahlstrand, E ^a,b   Svensson, K ^a   Persson, L ^a   Tidefelt, U ^a,b   Soderquist B ^a,b  

^a ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^b ÖREBRO UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

POLYPEPTIDE ANTIBIOTIC AGENT; TEICOPLANIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BLOOD CULTURE; BLOODSTREAM INFECTION; CLINICAL EVALUATION; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; EPSILOMETER TEST; HEMATOLOGIC MALIGNANCY; HUMAN; LONG TERM CARE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SPECIES DIFFERENCE; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HAEMOLYTICUS;

ANTI-BACTERIAL AGENTS; BACTEREMIA; COAGULASE; DRUG RESISTANCE, MICROBIAL; GLYCOPEPTIDES; HEMATOLOGIC NEOPLASMS; HUMANS; IMMUNOCOMPROMISED HOST; MICROBIAL SENSITIVITY TESTS; RETROSPECTIVE STUDIES; SPECIES SPECIFICITY; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HAEMOLYTICUS; SWEDEN; TEICOPLANIN; VANCOMYCIN;

EID: 80054774222     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-011-1228-8     Document Type: Article

References (36)

1. KL Rogers PD Fey ME Rupp 2009 Coagulase-negative staphylococcal infections Infect Dis Clin North Am 23 1 73 98 19135917 10.1016/j.idc.2008.10. 001
2. AP Wilson MD O'Hare D Felmingham RN Grüneberg 1986 Teicoplanin-resistant coagulase-negative staphylococcus Lancet 2 8513 973 2877149 10.1016/S0140-6736(86)90622-7 1:STN:280:DyaL2s%2FjvVaquw%3D%3D (Pubitemid 17197858)
3. RS Schwalbe JT Stapleton PH Gilligan 1987 Emergence of vancomycin resistance in coagulase-negative staphylococci N Engl J Med 316 15 927 931 3821839 10.1056/NEJM198704093161507 1:STN:280:DyaL2s7ksVGhsA%3D%3D (Pubitemid 17041985)
4. CJ Henwood DM Livermore AP Johnson D James M Warner A Gardiner The Linezolid Study Group 2000 Susceptibility of gram-positive cocci from 25 UK hospitals to antimicrobial agents including linezolid J Antimicrob Chemother 46 6 931 940 11102412 10.1093/jac/46.6.931 1:CAS:528:DC%2BD3MXotlGk (Pubitemid 32000604)
5. I Santos Sanches R Mato H de Lencastre A Tomasz 2000 Patterns of multidrug resistance among methicillin-resistant hospital isolates of coagulase-positive and coagulase-negative staphylococci collected in the international multicenter study RESIST in 1997 and 1998 Microb Drug Resist 6 3 199 211 11144420 10.1089/mdr.2000.6.199 1:STN:280:DC%2BD3M3htFSnsw%3D%3D
6. AJ de Neeling WJ van Leeuwen LM Schouls CS Schot A van Veen-Rutgers AJ Beunders AG Buiting C Hol EE Ligtvoet PL Petit LJ Sabbe AJ van Griethuysen JD van Embden 1998 Resistance of staphylococci in The Netherlands: surveillance by an electronic network during 1989-1995 J Antimicrob Chemother 41 1 93 101 9511042 10.1093/jac/41.1.93 (Pubitemid 28064255)
7. D Felmingham DF Brown CJ Soussy European Glycopeptide Resistance Survey Study Group 1998 European Glycopeptide Susceptibility Survey of gram-positive bacteria for 1995 Diagn Microbiol Infect Dis 31 4 563 571 9764397 10.1016/S0732-8893(98)00053-4 1:STN:280:DyaK1cvjs1yrug%3D%3D (Pubitemid 28414499)
8. JW Froggatt JL Johnston DW Galetto GL Archer 1989 Antimicrobial resistance in nosocomial isolates of Staphylococcus haemolyticus Antimicrob Agents Chemother 33 4 460 466 2729941 1:CAS:528:DyaL1MXit1yntL8%3D (Pubitemid 19094273)
9. FW Goldstein A Coutrot A Sieffer JF Acar 1990 Percentages and distributions of teicoplanin- and vancomycin-resistant strains among coagulase-negative staphylococci Antimicrob Agents Chemother 34 5 899 900 2141780 1:STN:280:DyaK3c3pslKhuw%3D%3D (Pubitemid 20142421)
10. RN Grüneberg W Hryniewicz 1998 Clinical relevance of a European collaborative study on comparative susceptibility of gram-positive clinical isolates to teicoplanin and vancomycin Int J Antimicrob Agents 10 4 271 277 9916900 10.1016/S0924-8579(98)00050-8 (Pubitemid 29048269)
11. L Herwaldt L Boyken M Pfaller 1991 In vitro selection of resistance to vancomycin in bloodstream isolates of Staphylococcus haemolyticus and Staphylococcus epidermidis Eur J Clin Microbiol Infect Dis 10 12 1007 1012 1802693 10.1007/BF01984921 1:CAS:528:DyaK38Xhs12qtb4%3D
12. KT Luh PR Hsueh LJ Teng HJ Pan YC Chen JJ Lu JJ Wu SW Ho 2000 Quinupristin-dalfopristin resistance among gram-positive bacteria in Taiwan Antimicrob Agents Chemother 44 12 3374 3380 11083643 10.1128/AAC.44.12.3374- 3380.2000 1:CAS:528:DC%2BD3MXhs1Kit7c%3D (Pubitemid 33009498)
13. K Hiramatsu N Aritaka H Hanaki S Kawasaki Y Hosoda S Hori Y Fukuchi I Kobayashi 1997 Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin Lancet 350 9092 1670 1673 9400512 10.1016/S0140-6736(97)07324-8 1:CAS:528:DyaK1cXns1em (Pubitemid 28036828)
14. K Sieradzki RB Roberts SW Haber A Tomasz 1999 The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection N Engl J Med 340 7 517 523 10021472 10.1056/NEJM199902183400704 1:STN:280:DyaK1M7jsVShsw%3D%3D (Pubitemid 29093287)
15. F Biavasco C Vignaroli R Lazzarini PE Varaldo 2000 Glycopeptide susceptibility profiles of Staphylococcus haemolyticus bloodstream isolates Antimicrob Agents Chemother 44 11 3122 3126 11036034 10.1128/AAC.44.11.3122- 3126.2000 1:CAS:528:DC%2BD3cXnvVSis70%3D
16. K Sieradzki RB Roberts D Serur J Hargrave A Tomasz 1998 Recurrent peritonitis in a patient on dialysis and prophylactic vancomycin Lancet 351 9106 880 881 9525371 10.1016/S0140-6736(05)70291-9 1:STN:280:DyaK1c7osVarsQ%3D%3D (Pubitemid 28121182)
17. K Sieradzki RB Roberts D Serur J Hargrave A Tomasz 1999 Heterogeneously vancomycin-resistant Staphylococcus epidermidis strain causing recurrent peritonitis in a dialysis patient during vancomycin therapy J Clin Microbiol 37 1 39 44 9854061 1:STN:280:DyaK1M7gt1Cnsw%3D%3D (Pubitemid 29004177)
18. WC Van Der Zwet YJ Debets-Ossenkopp E Reinders M Kapi PH Savelkoul RM Van Elburg K Hiramatsu CM Vandenbroucke-Grauls 2002 Nosocomial spread of a Staphylococcus capitis strain with heteroresistance to vancomycin in a neonatal intensive care unit J Clin Microbiol 40 7 2520 2525 10.1128/JCM.40.7.2520-2525. 2002 (Pubitemid 34747358)
19. IM Gould 2008 Clinical relevance of increasing glycopeptide MICs against Staphylococcus aureus Int J Antimicrob Agents 31 Suppl 2 1 9 18485997 10.1016/S0924-8579(08)70002-5 1:CAS:528:DC%2BD1cXlvFyhtLs%3D (Pubitemid 351657677)
20. M Bertin A Muller X Bertrand C Cornette M Thouverez D Talon 2004 Relationship between glycopeptide use and decreased susceptibility to teicoplanin in isolates of coagulase-negative staphylococci Eur J Clin Microbiol Infect Dis 23 5 375 379 15112071 10.1007/s10096-004-1129-1 1:CAS:528: DC%2BD2cXjs1yksrs%3D (Pubitemid 38797719)
21. K Boisson M Thouverez D Talon X Bertrand 2002 Characterisation of coagulase-negative staphylococci isolated from blood infections: incidence, susceptibility to glycopeptides, and molecular epidemiology Eur J Clin Microbiol Infect Dis 21 9 660 665 12373498 10.1007/s10096-002-0799-9 1:CAS:528: DC%2BD38Xns1Ogur8%3D
22. E Tacconelli M Tumbarello KG Donati M Bettio T Spanu F Leone LA Sechi S Zanetti G Fadda R Cauda 2001 Glycopeptide resistance among coagulase-negative staphylococci that cause bacteremia: epidemiological and clinical findings from a case-control study Clin Infect Dis 33 10 1628 1635 11595984 10.1086/323676 1:CAS:528:DC%2BD3MXoslWnsLo%3D (Pubitemid 33044525)
23. F Biavasco C Vignaroli PE Varaldo 2000 Glycopeptide resistance in coagulase-negative staphylococci Eur J Clin Microbiol Infect Dis 19 6 403 417 10947214 10.1007/s100960000299 1:CAS:528:DC%2BD3cXlvFWgsbk%3D (Pubitemid 30458648)
24. K Hiramatsu H Hanaki 1998 Glycopeptide resistance in staphylococci Curr Opin Infect Dis 11 6 653 658 17035739 10.1097/00001432-199812000-00002 1:CAS:528:DyaK1MXht1WqsLg%3D (Pubitemid 29020872)
25. H Cherif G Kronvall M Björkholm M Kalin 2003 Bacteraemia in hospitalised patients with malignant blood disorders: a retrospective study of causative agents and their resistance profiles during a 14-year period without antibacterial prophylaxis Hematol J 4 6 420 426 14671614 10.1038/sj.thj.6200334 (Pubitemid 38088787)
26. TR Walsh A Bolmström A Qwärnström P Ho M Wootton RA Howe AP MacGowan D Diekema 2001 Evaluation of current methods for detection of staphylococci with reduced susceptibility to glycopeptides J Clin Microbiol 39 7 2439 2444 11427551 10.1128/JCM.39.7.2439-2444.2001 1:CAS:528: DC%2BD3MXlsFSjsr8%3D (Pubitemid 32606216)
27. SN Leonard KL Rossi KL Newton MJ Rybak 2009 Evaluation of the Etest GRD for the detection of Staphylococcus aureus with reduced susceptibility to glycopeptides J Antimicrob Chemother 63 3 489 492 19136530 10.1093/jac/dkn520 1:CAS:528:DC%2BD1MXitVSitrs%3D
28. M Maniati E Petinaki Kontos AN Maniatis I Spiliopoulou D Petropoulou-Mylona H Malamou-Lada L Spaliara C Koutsia-Carouzou 2005 Rapid increase in numbers of Staphylococcus epidermidis strains with reduced susceptibility to teicoplanin in Greece Int J Antimicrob Agents 25 4 346 348 15849876 10.1016/j.ijantimicag.2005.01.015 1:CAS:528:DC%2BD2MXisFGktLc%3D (Pubitemid 40387284)
29. F Trueba E Garrabe R Hadef R Fabre JD Cavallo K Tsvetkova O Chesneau 2006 High prevalence of teicoplanin resistance among Staphylococcus epidermidis strains in a 5-year retrospective study J Clin Microbiol 44 5 1922 1923 16672444 10.1128/JCM.44.5.1922-1923.2006 1:CAS:528:DC%2BD28XltlGnsb0%3D (Pubitemid 43726305)
30. A Soriano F Marco JA Martínez E Pisos M Almela VP Dimova D Alamo M Ortega J Lopez J Mensa 2008 Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia Clin Infect Dis 46 2 193 200 18171250 10.1086/524667 1:CAS:528:DC%2BD1cXhvVClsbk%3D (Pubitemid 351269157)
31. TP Lodise J Graves A Evans E Graffunder M Helmecke BM Lomaestro K Stellrecht 2008 Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin Antimicrob Agents Chemother 52 9 3315 3320 18591266 10.1128/AAC.00113-08 1:CAS:528:DC%2BD1cXhtF2gt77I
32. A Srinivasan JD Dick TM Perl 2002 Vancomycin resistance in staphylococci Clin Microbiol Rev 15 3 430 438 12097250 10.1128/CMR.15.3.430-438.2002 1:CAS:528:DC%2BD38XlvV2msbc%3D (Pubitemid 34761351)
33. J Cremniter A Slassi JC Quincampoix V Sivadon-Tardy T Bauer R Porcher A Lortat-Jacob P Piriou T Judet JL Herrmann JL Gaillard M Rottman 2010 Decreased susceptibility to teicoplanin and vancomycin in coagulase-negative staphylococci isolated from orthopedic-device-associated infections J Clin Microbiol 48 4 1428 1431 20164270 10.1128/JCM.02098-09
34. S Natoli C Fontana M Favaro A Bergamini GP Testore S Minelli MC Bossa M Casapulla G Broglio A Beltrame L Cudillo R Cerretti F Leonardis 2009 Characterization of coagulase-negative staphylococcal isolates from blood with reduced susceptibility to glycopeptides and therapeutic options BMC Infect Dis 9 83 19497104 10.1186/1471-2334-9-83
35. MJ Rybak BM Lomaestro JC Rotschafer RC Moellering Jr WA Craig M Billeter JR Dalovisio DP Levine 2009 Therapeutic monitoring of vancomycin in adults summary of consensus recommendations from the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists Pharmacotherapy 29 11 1275 1279 19873687 10.1592/phco.29.11.1275 1:CAS:528:DC%2BD1MXhsVeqsrjK
36. WT Hughes D Armstrong GP Bodey EJ Bow AE Brown T Calandra R Feld PA Pizzo KV Rolston JL Shenep LS Young 2002 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer Clin Infect Dis 34 6 730 751 11850858 10.1086/339215 (Pubitemid 34194843)